JPWO2021081601A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021081601A5
JPWO2021081601A5 JP2022525870A JP2022525870A JPWO2021081601A5 JP WO2021081601 A5 JPWO2021081601 A5 JP WO2021081601A5 JP 2022525870 A JP2022525870 A JP 2022525870A JP 2022525870 A JP2022525870 A JP 2022525870A JP WO2021081601 A5 JPWO2021081601 A5 JP WO2021081601A5
Authority
JP
Japan
Prior art keywords
amh
seq
amino acid
analog
acid residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022525870A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023501308A (ja
JP2023501308A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2020/051187 external-priority patent/WO2021081601A1/en
Publication of JP2023501308A publication Critical patent/JP2023501308A/ja
Publication of JPWO2021081601A5 publication Critical patent/JPWO2021081601A5/ja
Publication of JP2023501308A5 publication Critical patent/JP2023501308A5/ja
Pending legal-status Critical Current

Links

JP2022525870A 2019-10-30 2020-10-30 抗ミュラー管ホルモンポリペプチド Pending JP2023501308A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2019904097 2019-10-30
AU2019904097A AU2019904097A0 (en) 2019-10-30 Anti-mullerian hormone polypeptides
PCT/AU2020/051187 WO2021081601A1 (en) 2019-10-30 2020-10-30 Anti-mullerian hormone polypeptides

Publications (3)

Publication Number Publication Date
JP2023501308A JP2023501308A (ja) 2023-01-18
JPWO2021081601A5 true JPWO2021081601A5 (https=) 2023-11-09
JP2023501308A5 JP2023501308A5 (https=) 2023-11-09

Family

ID=75714709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022525870A Pending JP2023501308A (ja) 2019-10-30 2020-10-30 抗ミュラー管ホルモンポリペプチド

Country Status (8)

Country Link
US (1) US20220411477A1 (https=)
EP (1) EP4051699A4 (https=)
JP (1) JP2023501308A (https=)
KR (1) KR20220155980A (https=)
CN (1) CN114945588A (https=)
AU (1) AU2020373165A1 (https=)
CA (1) CA3156607A1 (https=)
WO (1) WO2021081601A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025049960A1 (en) * 2023-08-30 2025-03-06 University Of Cincinnati Enhancing the production of anti-mullerian hormone through modification of its prodomain
WO2025085972A1 (en) * 2023-10-27 2025-05-01 Monash University Anti-mullerian hormone agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009012357A2 (en) * 2007-07-17 2009-01-22 The General Hospital Corporation Methods to identify and enrich for populations of ovarian cancer stem cells and somatic ovarian stem cells and uses thereof
WO2010017290A1 (en) * 2008-08-05 2010-02-11 The Trustees Of Columbia University In The City Of New York Müllerian inhibiting substance (mis) analogues
CA2837472A1 (en) * 2011-05-27 2012-12-06 Fox Chase Cancer Center Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
AU2013342190B2 (en) * 2012-11-09 2018-11-08 Ansh Labs Llc Antibody compositions and immunoassay methods to detect isoforms of Anti-Mullerian Hormone
US11230583B2 (en) * 2015-11-26 2022-01-25 Hudson Institute of Medical Research Inhibin analogs
EP3257867A1 (fr) * 2016-06-17 2017-12-20 Biomérieux Procédé de préparation d'anticorps anti-amh et leurs utilisations
WO2018112168A1 (en) * 2016-12-14 2018-06-21 The General Hospital Corporation Mullerian inhibiting substance (mis) proteins for ovarian and uterine oncoprotection, and ovarian reserve and uterine preservation
US11261225B2 (en) * 2017-02-10 2022-03-01 Institute For Cancer Research Chimera of bone morphogenic protein 2 and the Müllerian-inhibiting substance type II receptor binding region of Müllerian-inhibiting substance

Similar Documents

Publication Publication Date Title
CN101622271B (zh) 抗微生物肽
Vigneaud et al. The synthesis of an octapeptide amide with the hormonal activity of oxytocin
Morgan et al. The amino acid sequence of human chorionic gonadotropin. The alpha subunit and beta subunit.
EP0665754B1 (en) Antimicrobial peptides
CN101155825B (zh) 抗微生物六肽
Schwabe et al. Relaxin: structures, functions, promises, and nonevolution
IL184429A (en) Heterologous fusion proteins comprising a glp-1 compound fused to another polypeptide, pharmaceutical formulations comprising them and use thereof in the preparation of medicaments
HU217843B (hu) Paratiroid hormon (PTH) rokon polipeptidek, eljárások ezek előállítására és az ezeket tartalmazó gyógyszerek osteoporosis kezelésére
JPH0532696A (ja) 副甲状腺ホルモン誘導体
CA2230885A1 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
NO143218B (no) Analogifremgangsmaate til fremstilling av nonapeptidamider med lh-rh aktivitet
CA2529179A1 (en) Recombinant adeno-associated virus vector for treatment of alzheimer disease
CA2223832A1 (en) Method for the treatment of corticosteroid induced osteopenia
JP2021505624A5 (https=)
JP2015504052A5 (https=)
JPS6094998A (ja) インシュリン誘導体の製法
AR006517A1 (es) Polipeptido que alcanza un total de alrededor de 30 aminoacidos; sustancia, peptidomimetico y composicion farmaceutica resultantes; usos del polipeptidoy proceso para la sintesis del polipeptido.
JP2004538320A5 (https=)
JPWO2021081601A5 (https=)
JPS617297A (ja) 治療用ｌｈｒｈ類似体
US12129312B2 (en) Peptide compound, application thereof and composition containing same
RU2503684C2 (ru) Иммуномодулирующие олигопептиды
Suzuki et al. Synthesis of every kinds of peptide fragments of bradykinin
JPWO2019113181A5 (https=)
CN106496329B (zh) 一种含有胶原蛋白结合结构域的融合蛋白